These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8197191

  • 1. Prostaglandin E2 elicits a morphological change in cultured orbital fibroblasts from patients with Graves ophthalmopathy.
    Smith TJ, Wang HS, Hogg MG, Henrikson RC, Keese CR, Giaever I.
    Proc Natl Acad Sci U S A; 1994 May 24; 91(11):5094-8. PubMed ID: 8197191
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin E2 alters human orbital fibroblast shape through a mechanism involving the generation of cyclic adenosine monophosphate.
    Wang HS, Keese CR, Giaever I, Smith TJ.
    J Clin Endocrinol Metab; 1995 Dec 24; 80(12):3553-60. PubMed ID: 8530598
    [Abstract] [Full Text] [Related]

  • 3. Assessment of rapid morphological changes associated with elevated cAMP levels in human orbital fibroblasts.
    Reddy L, Wang HS, Keese CR, Giaever I, Smith TJ.
    Exp Cell Res; 1998 Dec 15; 245(2):360-7. PubMed ID: 9851877
    [Abstract] [Full Text] [Related]

  • 4. Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts.
    Smith TJ, Sempowski GD, Wang HS, Del Vecchio PJ, Lippe SD, Phipps RP.
    J Clin Endocrinol Metab; 1995 Sep 15; 80(9):2620-5. PubMed ID: 7673404
    [Abstract] [Full Text] [Related]

  • 5. Unique properties of orbital connective tissue underlie its involvement in Graves' disease.
    Smith TJ.
    Minerva Endocrinol; 2003 Sep 15; 28(3):213-22. PubMed ID: 14605603
    [Abstract] [Full Text] [Related]

  • 6. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy.
    Smith TJ, Koumas L, Gagnon A, Bell A, Sempowski GD, Phipps RP, Sorisky A.
    J Clin Endocrinol Metab; 2002 Jan 15; 87(1):385-92. PubMed ID: 11788681
    [Abstract] [Full Text] [Related]

  • 7. Novel aspects of orbital fibroblast pathology.
    Smith TJ.
    J Endocrinol Invest; 2004 Mar 15; 27(3):246-53. PubMed ID: 15165000
    [Abstract] [Full Text] [Related]

  • 8. Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture.
    Sorisky A, Pardasani D, Gagnon A, Smith TJ.
    J Clin Endocrinol Metab; 1996 Sep 15; 81(9):3428-31. PubMed ID: 8784110
    [Abstract] [Full Text] [Related]

  • 9. Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes.
    Koumas L, Smith TJ, Phipps RP.
    Eur J Immunol; 2002 Feb 15; 32(2):477-85. PubMed ID: 11813166
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
    Stadlmayr W, Spitzweg C, Bichlmair AM, Heufelder AE.
    Thyroid; 1997 Feb 15; 7(1):3-12. PubMed ID: 9086563
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
    Dik WA, Virakul S, van Steensel L.
    Exp Eye Res; 2016 Jan 15; 142():83-91. PubMed ID: 26675405
    [Abstract] [Full Text] [Related]

  • 15. Pirfenidone attenuates IL-1β-induced COX-2 and PGE2 production in orbital fibroblasts through suppression of NF-κB activity.
    Choi YH, Back KO, Kim HJ, Lee SY, Kook KH.
    Exp Eye Res; 2013 Aug 15; 113():1-8. PubMed ID: 23664858
    [Abstract] [Full Text] [Related]

  • 16. Leukoregulin upregulation of prostaglandin endoperoxide H synthase-2 expression in human orbital fibroblasts.
    Cao HJ, Smith TJ.
    Am J Physiol; 1999 Dec 15; 277(6):C1075-85. PubMed ID: 10600759
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
    Xiong H, Wu M, Zou H, Jiang S, Yi H, Yi T, Wang Q, Liu D, Zhou Y, Wei C, Zhou X.
    Mol Vis; 2018 Dec 15; 24():509-517. PubMed ID: 30090014
    [Abstract] [Full Text] [Related]

  • 19. Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.
    Feldon SE, Park DJ, O'Loughlin CW, Nguyen VT, Landskroner-Eiger S, Chang D, Thatcher TH, Phipps RP.
    Invest Ophthalmol Vis Sci; 2005 Nov 15; 46(11):3913-21. PubMed ID: 16249464
    [Abstract] [Full Text] [Related]

  • 20. [Effects of interleukin on orbital fibroblasts of patients with Graves' ophthalmopathy].
    Zhang XJ, Luo QL, Zhang MX.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar 15; 35(2):241-3. PubMed ID: 15071929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.